adapt-232
Trade name: Chisan
Botanicalexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Apr 19, 2021 (NCT04795557)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04795557 | Phase 2/Phase 3 (Phase 3) | Apr 19, 2021 | Government of Georgia, Phytomed AB, Swedish Herbal Institute AB, Tbilisi State Medical University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Georgia | Government | 1 | 0 | 1 | 2021 |
| Phytomed AB | For profit | 1 | 0 | 1 | 2021 |
| Swedish Herbal Institute AB | For profit | 1 | 1 | 1 | 2021 |
| Tbilisi State Medical University | Academic/Hospital | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1